Incyte (INCY) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.02% |
| Dec 31, 2025 | -2.88% |
| Sep 30, 2025 | 1,150.28% |
| Jun 30, 2025 | -83.18% |
| Mar 31, 2025 | -30.21% |
| Dec 31, 2024 | 22.63% |
| Sep 30, 2024 | 154.01% |
| Jun 30, 2024 | -363.04% |
| Mar 31, 2024 | 48.12% |
| Dec 31, 2023 | -0.07% |
| Sep 30, 2023 | -51.77% |
| Jun 30, 2023 | 390.26% |
| Mar 31, 2023 | -137.23% |
| Dec 31, 2022 | -4.29% |
| Sep 30, 2022 | 70.18% |
| Jun 30, 2022 | -19.27% |
| Mar 31, 2022 | 87.03% |
| Dec 31, 2021 | -54.78% |
| Sep 30, 2021 | 47.50% |
| Jun 30, 2021 | -16.09% |
| Mar 31, 2021 | 92.04% |
| Dec 31, 2020 | -41.07% |
| Sep 30, 2020 | -32.40% |
| Jun 30, 2020 | 139.42% |
| Mar 31, 2020 | -619.24% |
| Dec 31, 2019 | -51.33% |
| Sep 30, 2019 | 76.79% |
| Jun 30, 2019 | -1.74% |
| Mar 31, 2019 | 85.67% |
| Dec 31, 2018 | -57.90% |
| Sep 30, 2018 | 514.60% |
| Jun 30, 2018 | 55.50% |
| Mar 31, 2018 | 123.34% |
| Dec 31, 2017 | -268.04% |
| Sep 30, 2017 | -54.52% |
| Jun 30, 2017 | 167.26% |
| Mar 31, 2017 | -283.98% |
| Dec 31, 2016 | -0.94% |
| Sep 30, 2016 | 442.18% |
| Jun 30, 2016 | -81.98% |
| Mar 31, 2016 | 33.83% |
| Dec 31, 2015 | 843.69% |
| Sep 30, 2015 | -42.32% |
| Jun 30, 2015 | 391.98% |
| Mar 31, 2015 | -110.25% |
| Dec 31, 2014 | 60.94% |
| Sep 30, 2014 | 290.88% |
| Jun 30, 2014 | 54.07% |
| Mar 31, 2014 | -171.14% |
| Dec 31, 2013 | 2.18% |
| Sep 30, 2013 | -247.88% |
| Jun 30, 2013 | -67.33% |
| Mar 31, 2013 | 212.40% |
| Dec 31, 2012 | 18.92% |
| Sep 30, 2012 | -411.15% |
| Jun 30, 2012 | 116.04% |
| Mar 31, 2012 | -36.76% |
| Dec 31, 2011 | 15.32% |
| Sep 30, 2011 | -52.84% |
| Jun 30, 2011 | 30.50% |
| Mar 31, 2011 | -261.38% |
| Dec 31, 2010 | 192.82% |
| Sep 30, 2010 | -967.32% |
| Jun 30, 2010 | -102.69% |